In conclusion, the NF-κB signaling pathway plays a crucial regulatory role in the progression of liver diseases, and a deeper understanding of SIRT1's involvement in the NF-κB signaling pathway offers great potential for developing novel strategies and therapies for liver diseases. This evidence concerns the gene NFKB1 and liver disorder.